Riber S.A. | Cash Flow

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
236.00
3,801.00
6,363.00
1,093.00
4,098.00
321
Depreciation, Depletion & Amortization
1,125.00
1,333.00
1,797.00
1,574.00
2,052.00
1,979
Other Funds
-
-
732.00
-
-
208
Funds from Operations
2,347.00
1,447.00
3,959.00
100.00
5,249.00
2,446
Changes in Working Capital
2,542.00
2,549.00
2,396.00
85.00
1,342.00
5,256
Net Operating Cash Flow
195.00
1,102.00
1,563.00
15.00
6,591.00
2,810
Capital Expenditures
2,271.00
1,215.00
576.00
489.00
975.00
Sale of Fixed Assets & Businesses
-
58.00
-
2,600.00
1.00
Purchase/Sale of Investments
-
108.00
112.00
70.00
-
Net Investing Cash Flow
2,587.00
881.00
979.00
1,634.00
1,566.00
Cash Dividends Paid - Total
757.00
-
-
-
-
Issuance/Reduction of Debt, Net
40.00
-
-
1,193.00
-
Net Financing Cash Flow
797.00
-
680.00
270.00
93.00
Net Change in Cash
3,588.00
237.00
1,854.00
1,890.00
4,877.00
Free Cash Flow
1,124.00
786.00
1,706.00
237.00
5,744.00
Deferred Taxes & Investment Tax Credit
85.00
-
-
-
-
62
Net Assets from Acquisitions
-
-
-
-
124.00
Other Sources
34.00
404.00
48.00
25.00
37.00
Change in Capital Stock
-
-
52.00
1,463.00
93.00
Exchange Rate Effect
9.00
16.00
8.00
1.00
55.00
Other Uses
350.00
20.00
339.00
432.00
505.00

About Riber

View Profile
Address
31, rue Casimir PĂ©rier
Bezons Ile-de-France 95870
France
Employees -
Website http://www.riber.com/fr.html
Updated 07/08/2019
Riber SA is engaged in the manufacture and sale of molecular beam epitaxy systems. Its products include chemical vapour deposition systems; molecular beam epitaxy cell, sources, and accessories; copper indium gallium selenide; organic light-emitting diode displays; and automates & software. The company operates in the Research and Development, Effusion Cells and Sources segments.